Liposomes are nanocarriers that deliver the payloads at the target site, leading to
therapeutic drug concentrations at the diseased site and reduced toxic effects in healthy …

Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

Surface functionalization of liposomes can play a key role in overcoming the current
limitations of nanocarriers to treat solid tumors, ie, biological barriers and physiological …

Liposomes are effective nanocarriers due to their ability to deliver encapsulated drugs to
diseased cells. Nevertheless, liposome delivery would be improved by enhancing the ability …

An overview of liposome-based drug-delivery carriers to cancer cells is presented.
Properties related to interfacial interactions between liposomes and the biological milieu that …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …

Liposomes are biodegradable and biocompatible self-forming spherical lipid bilayer
vesicles. They can encapsulate and deliver one or more hydrophobic and hydrophilic …

Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …

In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …

The development of therapeutic resistance to targeted anticancer therapies remains a
significant clinical problem, with intratumoral heterogeneity playing a key role. In this context …